POLX.LLSEHealthcare · Medical - Devices

Polarean Imaging plc

$0.08-20.00%($-0.02)

TickerSpark Score

68/100

Solid

100

Valuation

Profitability

100

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a POLX.L research report →

52-Week Range1% of range

Low $0.06

Current $0.08

High $1.60

Companypolarean.com

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach.

CEO: Christopher Richard Von Jako
IPO: 2018
Employees: 29
HQ: London, NC, US

Price Chart

-93.85% · this period

Valuation

Market Cap: $965.63K
P/E: -0.17
P/S: 0.65
P/B: 0.16
EV/EBITDA: 0.81
Div Yield: 0.00%

Profitability

Gross Margin: 16.36%
Op Margin: -390.04%
Net Margin: -373.62%
ROE: -73.99%
ROIC: -91.67%

Growth & Income

Revenue: $2.42M · 171.42%
Net Income: $-6,683,275 · 43.77%
EPS: $-0.01 · 81.18%
Op Income: $-6,847,118
FCF YoY: 58.83%

Performance & Tape

52W High: $1.60
52W Low: $0.06
50D MA: $0.17
200D MA: $0.82
Beta: 0.28
Avg Volume: 18.32M

Get TickerSpark's AI analysis on POLX.L

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime